MMC
PACB icon

MDV Management Company’s Pacific Biosciences PACB Stock Holding History

MDV Management Company’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$43.9M Buy
+5,598,397
New +$35.8M 14.82% 3

Other funds holding PACB

MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

MDV Management Company's PACB Position: Q4 2014 in Review

MDV Management Company opened a new position in Pacific Biosciences (PACB) in Q4 2014: 5,598,397 shares worth $43.9M. The stake represents 14.82% of the portfolio and ranks #3 among its holdings.

101 funds tracked by Wall St. Rank hold PACB as of Q4 2014.

  • MDV Management Company held 5,598,397 shares of Pacific Biosciences worth $43.9M as of Q4 2014.
  • Pacific Biosciences was a new MDV Management Company position in Q4 2014.
  • Pacific Biosciences made up 14.82% of MDV Management Company's portfolio in Q4 2014, its #3 holding.
  • 101 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2014.

Based on MDV Management Company's 13F filing for Q4 2014, filed 17 Feb 2015.